Regulating the regulator: Negative regulation of Cbl ubiquitin ligases

Trends in Biochemical Sciences

Volumn 31, Issue 2, 2006, Pages 79-88

  Ryan, Philip E ^a,b   Davies, Gareth C ^a   Nau, Marion M ^a   Lipkowitz, Stanley ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; CD28 ANTIGEN; CORTACTIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; STS 1 PROTEIN; STS 2 PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG;

CANCER; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATOR GENE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ANTIGENS, CD28; AUTOIMMUNE DISEASES; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CDC42 GTP-BINDING PROTEIN; CELL CYCLE PROTEINS; CORTACTIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NEOPLASMS; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS, VIRAL; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-KIT; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; UBIQUITIN-PROTEIN LIGASES;

EID: 32344451150     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2005.12.004     Document Type: Review

References (101)

1. A.M. Weissman Themes and variations on ubiquitylation Nat. Rev. Mol. Cell Biol. 2 2001 169 178
2. I. Dikic Cbl signaling networks in the regulation of cell function Cell. Mol. Life Sci. 60 2003 1805 1827
3. L. Duan The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling Immunity 21 2004 7 17
4. C.B. Thien, and W.Y. Langdon Cbl: many adaptations to regulate protein tyrosine kinases Nat. Rev. Mol. Cell Biol. 2 2001 294 307
5. A.K. Ghosh Biochemical basis for the requirement of kinase activity for Cbl-dependent ubiquitinylation and degradation of a target tyrosine kinase J. Biol. Chem. 279 2004 36132 36141
6. C.K. Kassenbrock, and S.M. Anderson Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations J. Biol. Chem. 279 2004 28017 28027
7. S.A. Ettenberg Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex J. Biol. Chem. 276 2001 27677 27684
8. S. Zeng Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl) Blood 105 2005 226 232
9. A. Magnifico WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation J. Biol. Chem. 278 2003 43169 43177
10. J. Bao Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors Proc. Natl. Acad. Sci. U. S. A. 100 2003 2438 2443
11. J. Zhang Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination J. Immunol. 169 2002 2236 2240
12. E.A. Feshchenko TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin Oncogene 23 2004 4690 4706
13. K. Kowanetz Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases J. Biol. Chem. 279 2004 32786 32795
14. A. Sanjay The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases Sci. STKE 2001 2001 PE40
15. G.R. Guy Sprouty: how does the branch manager work? J. Cell Sci. 116 2003 3061 3068
16. W.J. Wu Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation Cell 114 2003 715 725
17. P. Timpson Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor Cancer Res. 65 2005 3273 3280
18. M.H. Schmidt Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex Mol. Cell. Biol. 24 2004 8981 8993
19. B. Zhang HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes Oncogene 24 2005 2585 2588
20. E. Mizuno Regulation of epidermal growth factor receptor: down-regulation by UBPY-mediated deubiquitination at endosomes Mol. Biol. Cell 16 2005 5163 5174
21. F. Gesbert Ubiquitination of the common cytokine receptor γc and regulation of expression by an ubiquitination/deubiquitination machinery Biochem. Biophys. Res. Commun. 334 2005 474 480
22. I. Amit Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding Genes Dev. 18 2004 1737 1752
23. P. Peschard Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein Mol. Cell 8 2001 995 1004
24. A. Mancini c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms J. Biol. Chem. 277 2002 14635 14640
25. M.F. Roussel A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes Proc. Natl. Acad. Sci. U. S. A. 87 1990 6738 6742
26. S.K. Muthuswamy Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers Mol. Cell. Biol. 19 1999 6845 6857
27. G. Levkowitz Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 Mol. Cell 4 1999 1029 1040
28. M. Kim Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation Oncogene 23 2004 1645 1655
29. M. Yokouchi Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins J. Biol. Chem. 276 2001 35185 35193
30. N. Zheng Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases Cell 102 2000 533 539
31. C.B. Thien RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation Mol. Cell 7 2001 355 365
32. U.G. Lopes p53-dependent induction of apoptosis by proteasome inhibitors J. Biol. Chem. 272 1997 12893 12896
33. G. Hu, and E.R. Fearon Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins Mol. Cell. Biol. 19 1999 724 732
34. Y. Wang CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins J. Cell. Biochem. 72 1999 119 134
35. Y. Wang c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following Csf-1 stimulation of macrophages J. Biol. Chem. 271 1996 17 20
36. C.J. Howlett, and S.M. Robbins Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation Oncogene 21 2002 1707 1716
37. D.K. Luttrell Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src Mol. Cell. Biol. 8 1988 497 501
38. M.C. Maa Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers Proc. Natl. Acad. Sci. U. S. A. 92 1995 6981 6985
39. R.B. Irby, and T.J. Yeatman Role of Src expression and activation in human cancer Oncogene 19 2000 5636 5642
40. D. Rotin Ubiquitination and endocytosis of plasma membrane proteins: role of Nedd4/Rsp5p family of ubiquitin-protein ligases J. Membr. Biol. 176 2000 1 17
41. A. Vecchione The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor Mol. Cell. Biol. 23 2003 3363 3372
42. R.J. Ingham The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture Oncogene 23 2004 1972 1984
43. F. Lafont, and K. Simons Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling Proc. Natl. Acad. Sci. U. S. A. 98 2001 3180 3184
44. J.R. Courbard Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH J. Biol. Chem. 277 2002 45267 45275
45. D.L. Mueller E3 ubiquitin ligases as T cell anergy factors Nat. Immunol. 5 2004 883 890
46. M.S. Jeon Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction Immunity 21 2004 167 177
47. Z. Xu CD28 activation does not down-regulate Cbl-b expression in aged rat T-lymphocytes Mech. Ageing Dev. 125 2004 595 602
48. G.C. Davies Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b Oncogene 23 2004 7104 7115
49. N. Carpino Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2 Immunity 20 2004 37 46
50. C.W. Fong Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function J. Biol. Chem. 278 2003 33456 33464
51. A.B. Hall hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl Curr. Biol. 13 2003 308 314
52. M.L. Lupher Jr The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70 J. Biol. Chem. 272 1997 33140 33144
53. E.S. Wong Evidence for direct interaction between Sprouty and Cbl J. Biol. Chem. 276 2001 5866 5875
54. K. Haglund Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation EMBO Rep. 6 2005 635 641
55. P. Lito Sprouty2 is necessary for the transformation of immortalized human fibroblasts by the H-Ras oncogene Proc. Am. Assoc. Cancer Res. 46 2005 233
56. R.A. Cerione Cdc42: new roads to travel Trends Cell Biol. 14 2004 127 132
57. G. Fritz Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters Br. J. Cancer 87 2002 635 644
58. G. Fritz Rho GTPases are over-expressed in human tumors Int. J. Cancer 81 1999 682 687
59. T. Kamai Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer Clin. Cancer Res. 10 2004 4799 4805
60. X. Zhang Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells Int. J. Hematol. 77 2003 263 273
61. S.J. Ahn Overexpression of βPix-a in human breast cancer tissues Cancer Lett. 193 2003 99 107
62. R.J. Daly Cortactin signalling and dynamic actin networks Biochem. J. 382 2004 13 25
63. M.H. Schmidt SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion J. Cell Sci. 116 2003 2845 2855
64. C. Chatellard-Causse Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization J. Biol. Chem. 277 2002 29108 29115
65. B. Chen The glioma-associated protein SETA interacts with AIP1/Alix and ALG-2 and modulates apoptosis in astrocytes J. Biol. Chem. 275 2000 19275 19281
66. D.R. Lowy, and J.T. Schiller Papillomaviruses and cervical cancer: pathogenesis and vaccine development J. Natl. Cancer Inst. Monogr. 23 1998 27 30
67. A.M. Kersemaekers Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis Clin. Cancer Res. 5 1999 577 586
68. S.W. Straight The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes J. Virol. 67 1993 4521 4532
69. D. Pim Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor Oncogene 7 1992 27 32
70. M.P. Czech PIP2 and PIP3: complex roles at the cell surface Cell 100 2000 603 606
71. R. Woscholski, and P.J. Parker Inositol lipid 5-phosphatases - traffic signals and signal traffic Trends Biochem. Sci. 22 1997 427 431
72. N.K. Prasad, and S.J. Decker SH2-containing 5′-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor J. Biol. Chem. 280 2005 13129 13136
73. D.J. Katzmann Receptor downregulation and multivesicular-body sorting Nat. Rev. Mol. Cell Biol. 3 2002 893 905
74. S. Naviglio UBPY: a growth-regulated human ubiquitin isopeptidase EMBO J. 17 1998 3241 3250
75. J. McCullough AMSH is an endosome-associated ubiquitin isopeptidase J. Cell Biol. 166 2004 487 492
76. Y. Zhu DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes J. Biol. Chem. 272 1997 51 57
77. T.S. Migone The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal Blood 98 2001 1935 1941
78. Q. Lu TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation Proc. Natl. Acad. Sci. U. S. A. 100 2003 7626 7631
79. L. Li, and S.N. Cohen Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells Cell 85 1996 319 329
80. Y.J. Chiang Cbl-b regulates the CD28 dependence of T-cell activation Nature 403 2000 216 220
81. K. Bachmaier Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b Nature 403 2000 211 216
82. N. Yokoi Cblb is a major susceptibility gene for rat type 1 diabetes mellitus Nat. Genet. 31 2002 391 394
83. R. Bergholdt CBLB variants in type 1 diabetes and their genetic interaction with CTLA4 J. Leukoc. Biol. 77 2005 579 585
84. Y. Yi Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells J. Immunol. 165 2000 6627 6634
85. W.Y. Langdon v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas Proc. Natl. Acad. Sci. U. S. A. 86 1989 1168 1172
86. T.J. Blake The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation EMBO J. 12 1993 2017 2026
87. T.J. Blake The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif Oncogene 6 1991 653 657
88. C.E. Andoniou Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene EMBO J. 13 1994 4515 4523
89. S.A. Bisson Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line Oncogene 21 2002 3677 3687
90. M. Naramura c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation Nat. Immunol. 3 2002 1192 1199
91. P. Peschard, and M. Park Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases Cancer Cell 3 2003 519 523
92. S.A. Ridge FMS mutations in myelodysplastic, leukemic, and normal subjects Proc. Natl. Acad. Sci. U. S. A. 87 1990 1377 1380
93. A. Baker FMS mutations in patients following cytotoxic therapy for lymphoma Leuk. Res. 19 1995 309 318
94. N. Normanno The ErbB receptors and their ligands in cancer: an overview Curr. Drug Targets 6 2005 243 257
95. R. Ebner, and R. Derynck Epidermal growth factor and transforming growth factor-α: differential intracellular routing and processing of ligand-receptor complexes Cell Regul. 2 1991 599 612
96. K.E. Longva Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies J. Cell Biol. 156 2002 843 854
97. H.A. Alwan Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination J. Biol. Chem. 278 2003 35781 35790
98. M.M. Nau, and S. Lipkowitz Comparative genomic organization of the cbl genes Gene 308 2003 103 113
99. L. Eichinger The genome of the social amoeba Dictyostelium discoideum Nature 435 2005 43 57
100. H.A. Schmidt TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing Bioinformatics 18 2002 502 504
101. R.D. Page TreeView: an application to display phylogenetic trees on personal computers Comput. Appl. Biosci. 12 1996 357 358